CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
CARM1 is an arginine methyltransferase often overexpressed in human cancer. Here, the authors show that EZH2 inhibition suppresses growth in CARM1-expressing epithelial ovarian cancer, and examine the mechanism of how CARM1 promotes EZH2-mediated tumor suppressor gene silencing.
Enregistré dans:
Auteurs principaux: | Sergey Karakashev, Hengrui Zhu, Shuai Wu, Yuhki Yokoyama, Benjamin G. Bitler, Pyoung-Hwa Park, Jeong-Heon Lee, Andrew V. Kossenkov, Krutika Satish Gaonkar, Huihuang Yan, Ronny Drapkin, Jose R. Conejo-Garcia, David W. Speicher, Tamas Ordog, Rugang Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d5feab71b5d34b35b80ea5240b6980bc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells
par: Shuai Wu, et autres
Publié: (2018) -
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
par: Jianhuang Lin, et autres
Publié: (2021) -
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation
par: Jie Zhou, et autres
Publié: (2019) -
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
par: Julia M. Kempf, et autres
Publié: (2021) -
Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens
par: Jesse H. Arbuckle, et autres
Publié: (2017)